Congratulations to Dr @kevinrouault.bsky.social, who has been awarded £1m from @cancerresearchuk.org to launch a clinical trial aiming to improve quality of life for people with myelodysplastic syndromes, a form of blood cancer with limited treatment options.
🧪 #medsky #oncosky @qmul.bsky.social
🔬 Watch how cancer and immune cells interact in a living system.
Scientists at BCI have developed mini lab-grown ovarian tumours that recreate the complex neighbourhood of cells in patients. Published today in @natcomms.nature.com.
Read more: bit.ly/4bMCrVg
🧪 #medsky #oncosky @qmul.bsky.social
onlinelibrary.wiley.com/doi/10.1111/...
Thrilled to share our work in BJH highlighting the therapeutic potential of targeting the WNT pathway to block the crosstalk among stromal and leukemic ALL cells to prevent chemoresistance.
Collab. w/ Bela Wrench
@foteinikal.bsky.social
@qmbci.bsky.social
Congratulations to Professor Michelle Lockley and Dr Oliver Pearce, who have been awarded prestigious @cancerresearchuk.org Programme Foundation Awards, worth nearly £1.5m each. Read more about their work seeking novel cancer therapy targets in our Q&A.
🧪 #medsky #oncosky @qmul.bsky.social
Today, on #WorldCancerDay, we’re taking you behind the scenes at Queen Mary's Barts Cancer Institute and introducing you to the people who are making progress possible.
Follow us to stay up to date with new developments.
🧪 #UnitedByUnique #MedSky #OncoSky @qmul.bsky.social @cancerresearchuk.org
Margaret, a participant in the study, has lived with her cancer for more than 13 years since her original diagnosis in 2012.
💬“I’m eternally grateful that Professor Kocher has given me all of these extra years to enjoy with my loved ones,” Margaret comments.
People with a rare eye cancer (uveal melanoma) that has spread to the liver may survive for longer when doctors take a more active approach to monitoring and treatment, according to results from Professor Hemant Kocher and team.
@qmul.bsky.social #medsky #oncosky 🧪
Transgender Awareness Week & we complete our episode with the wonderful Dr Alison Berner⭐️
🎙️ UCATS & OUTpatients
work supporting the transgender community
🎙️Don’t let fear of Saying the wrong thing stop you DOING the right things⭐️
@drallycat.bsky.social
@oncodaily.bsky.social
@qmbci.bsky.social
📰 15 years of research by Prof. Tatjana Crnogorac-Jurcevic at BCI have led to the launch of Procyon Diagnostics, a new Queen Mary Innovation #spinout company developing a simple test for early #PancreaticCancer detection.
@qmul.bsky.social | @qminnovation.bsky.social
🧪 #medsky #oncosky
Read more ⤵️
Interested in carrying out research in cancer Radiotherapy and Radiobiology? Applications are open now for our PhD programme for 2026 intake!
@kingscollegelondon.bsky.social @qmbci.bsky.social @crick.ac.uk @ucl.ac.uk
crukradnet.colcc.ac.uk/phd-students...
The PhD will supervised by both myself and @mirazrahman.bsky.social at @qmbci.bsky.social and @kingscollegelondon.bsky.social, and is an outstanding opportunity to gain expertise in structural biology, medicinal chemistry, and cancer biology, at the cutting edge of translational oncology.
Proud to partner @cancerresearchuk.org and Windsor Fellowship to offer Black Leaders in Cancer #PhD scholarships. Check our projects and apply by Weds 5 Nov: https://www.colcc.ac.uk/black-leaders-phd-programme/ @qmbci.bsky.social @kingslsm.bsky.social @uclmedsci.bsky.social @crick.ac.uk #CRUKFunded
Check out some of the #PhD projects we have on offer, starting Sept 2026. Find out more and apply by noon, Weds 5 Nov: https://www.colcc.ac.uk/phd-studentships/ @qmbci.bsky.social @kingslsm.bsky.social @uclmedsci.bsky.social @crick.ac.uk #CRUKFunded
Our first Centre for Cancer Evolution PI retreat! A wonderful day at Goodenough House discussing science, strategy and forging new collaborations @qmbci.bsky.social
Come and join us at the Barts Cancer Institute @qmbci.bsky.social ! Our medical school, part of Queen Mary University of London @qmulfmd.bsky.social is hiring 10 professors!! www.veredus.co.uk/job/job-747a/. Contact me for a chat if interested.
Scientific Review Paper Published in BJUI Compass, titled: Emerging tools for the early detection of prostate cancer. Written by Haider et al.
Could imaging, genetic and biomarker tests improve early #ProstateCancer detection?
A team led by Prof Prabhakar Rajan @qmbci.bsky.social explore different detection strategies in their latest publication in @bjuijournal.bsky.social.
Grab a ☕ and read: doi.org/10.1002/bco2...
📰 A new AI tool could help doctors identify which skin cancers are most likely to spread.
We spoke to Professor Alex Wang and Dr Emilia Peleva to find out more about their new study and next steps ⬇
@qmul.bsky.social | @cruk-cityoflondon.bsky.social
🧪 #medsky #oncosky #ArtificialIntelligence
🎉 Join us in congratulating four BCI researchers who have been promoted!
Promoted to Professor:
🔹Professor Angus Cameron
🔹Professor Jun Wang
Promoted to Senior Lecturer:
🔹Dr Diu Nguyen
Promoted to Reder:
🔹Dr Miguel Ganuza
@qmul.bsky.social @qmulfmd.bsky.social @cruk-cityoflondon.bsky.social
📰Rogue DNA rings could provide early clues to brain cancer’s growth, according to new results co-led by Dr @benjaminwerner.bsky.social, as part of international @cancergrand.bsky.social collaboration
@qmul.bsky.social | @crick.ac.uk | @stanford.edu | @aacrjournals.bsky.social | #medsky #oncosky 🧪
3/ The trial results showed that people given the treatment lived nearly twice as long as those given standard chemotherapy. Around 30% of people achieved a complete remission following treatment, meaning all detectable signs of the disease had disappeared.
2/ 💬Prof Powles says: "This is a landmark moment in the care of advanced bladder cancer – the first of its kind in 40 years."
📰 NICE has approved a breakthrough life-extending combination treatment for bladder cancer for use in the NHS from today, following trials led by Prof Tom Powles at BCI @qmul.bsky.social.
🧪 #medsky #oncosky #bladdercancer
@qmulfmd.bsky.social | @cruk-cityoflondon.bsky.social
Fantastic news, congratulations to Professor
Tom Powles and team for all their work leading the clinical trials for this breakthrough treatment!
Proud to be named as a finalist in the University of the Year category in the 2025 UK Social Mobility Awards, which recognise organisations taking action to level the playing field for people from less-advantaged socio-economic backgrounds.
Roll on October 2nd when the winners will be announced!
Congratulations to our team at the Pancreatic Cancer Research Fund Tissue Bank (PCRFTB), who have achieved a landmark international accreditation 🎉
They have become the first in England to receive ISO 20387:2018 accreditation, an international standard recognising excellence in biobanking. 🧪
BCI’s Prof Jane Sosabowski and Dr Jennifer Young will lead a £1m project studying radiolabelled nanomedicines. The team will track how these nanomedicines move within the body, helping to improve tumour targeting and avoid unintended accumulation and side effects.
💡 £10 million has been awarded to a new UK-wide partnership investigating innovative healthcare nanotechnologies.
The initiative, funded by EPSRC, will unite researchers at BCI @qmul.bsky.social, @kingscollegelondon.bsky.social & @universityofleeds.bsky.social.
#medsky #oncosky 🧪
🏆The winner of our 2025 Image Competition is Dr Elly Tyler of @qmbci.bsky.social, for her image 'Where Collagen Burns and Immunity Falters'!
In this breast tumour tissue, collagen fibres in the extracellular matrix blaze like wildfire.
🌟 We recently welcomed 43 aspiring young scientists to BCI as part of two #WorkExperience programmes (STARS and BURSThrough) designed to break down perceived barriers to #HigherEducation and ignite students' aspirations to pursue careers in #STEM 🧪
@qmul.bsky.social | @cruk-cityoflondon.bsky.social
The research was published in @hemasphere-journal.bsky.social and used breathalyser technology developed by @owlstonemedical.bsky.social.
